[Skip to Content]
[Skip to Content Landing]
Citations 0
June 17, 1998

Use of Serotonin Reuptake Inhibitors by Women of Childbearing Potential

Author Affiliations

Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor

JAMA. 1998;279(23):1873-1874. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-23-jbk0617

To the Editor.— As an investigator whose research1 evaluating the effects of fluoxetine (Prozac) exposure on pregnancy outcomes was misrepresented in the letter by Dr Yonkers and colleagues,2 I am concerned that health care practitioners might be misled, resulting in harm to patients. Yonkers and colleagues ignored the interpretations and conclusions of other authors,1,3,4 such as Chambers et al, who noted that "the rate of spontaneous pregnancy loss did not differ significantly between women treated with fluoxetine and control women."4